Explore the benefits of shorter, simpler breast cancer treatments through subcutaneous therapy, enhancing patient comfort and ...
In 2020, Australia massively increased welfare payments and conducted a live experiment in ending poverty, but when the ...
Women often feel unsupported while postpartum, a time when they are most at risk for physical, emotional, and social ...
They will also be permitted to prepare “a device which will enable [the patient] to self-administer the substance“ i.e., set ...
Guest writer Brian Howard faced numerous difficulties after being diagnosed with MS. Even so, people can still lean on him ...
Patient education conversations emphasize 3 core elements: equivalent efficacy supported by rigorous pharmacokinetic and clinical trial data, comparable safety profiles with identical immune-related ...
Longevity hacks and body tracking have become an obsession for the super-rich. Now a young Australian is making millions by ...
Michael Fraley breaks down what paramedics need to know about what’s changed — and what hasn’t — in the new resuscitation ...
A U.S. District Court Judge in Long Island, Gary Brown discovered magic as a child. He says learning about the ‘art of ...
Guard Therapeutics (publ) today announced top-line results from the company's Phase 2b POINTER study evaluating the investigational drug candidate RMC-035 as a kidney-protective therapy in patients un ...
(Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka; hereinafter "Alpha Fusion") today announced the initiation of a company-sponsored Phase I clinical trial (jRCT2031250472) of the alpha-emitting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results